Enterprise AI Analysis
Clinical-grade autonomous cytopathology through whole-slide edge tomography
Cytopathology, often abbreviated as cytology, has a central role in the early detection of cancer, owing to its speed, simplicity and minimally invasive nature. However, its effectiveness is limited by variability in diagnostic accuracy stemming from subjective visual interpretation. This paper presents a clinical-grade autonomous cytopathology pipeline that combines high-resolution, real-time optical whole-slide tomography with edge computing to deliver end-to-end automation.
Executive Impact & Key Metrics
Our autonomous cytopathology platform redefines diagnostic accuracy and efficiency. By integrating high-resolution optical tomography with AI-driven analysis at the edge, the system achieves practical performance in imaging speed, quality, and data volume. This enables streamlined storage, accelerated analysis, and comprehensive morphological profiling for an objective and reproducible diagnostic paradigm.
Single-Cell LSIL Detection
Single-Cell HSIL Detection
Typical Imaging Speed (10 layers)
Data Size (Low Compression)
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Integrated 3D Imaging Pipeline
Our edge computer-integrated optical whole-slide tomograph combines high-speed 3D imaging with real-time data compression at the source. This enables rapid acquisition of gigavoxel 3D whole-slide images, resolving subcellular structures with high fidelity at 220 nm lateral and 1 µm axial resolution. Localized data compression using HEVC format accelerates AI-driven analysis and streamlines storage, ensuring practical performance in imaging speed, quality, and data volume.
Enterprise Process Flow
3D Image Acquisition (Edge Device)
→
Real-time 3D Reconstruction & Compression
→
Transmit to Backend Server
→
Whole-Slide Stitching & Storage
→
AI-Driven Cell Analysis (YOLOX, MaxViT, CMD)
→
Autonomous Diagnostic Reporting
AI-Powered Classification Accuracy
The platform employs a YOLOX-based model for 3D cell detection, followed by MaxViT-based vision transformers for cell type classification. This AI model achieves high accuracy and reliability, with specificity exceeding 98% across all classes and AUC values greater than 0.99 at the single-cell level for detecting LSILs, HSILs, and adenocarcinoma cells. It demonstrates robust performance even in dense or aggregated cell populations, enabling the development of high-performance AI for accurate cell classification.
99%
Single-Cell Classification Accuracy (AUC > 0.99 for LSILs/HSILs/Adenocarcinoma)
Population-Wide Morphological Profiling with CMD
A key innovation is the Cluster of Morphological Differentiation (CMD), an image-derived analogue of flow cytometry markers. The CMD framework allows for population-wide morphological profiling, enabling comprehensive interpretation of cellular distributions through scatter plots, hierarchical gating, and dimensionality reduction (UMAP). This enhances interpretability, error detection, and the discovery of new phenotypes, establishing an objective, reproducible, and discovery-driven diagnostic paradigm.
| Feature | CMD-Based Analysis | Traditional Cytology |
|---|---|---|
| Interpretability |
|
|
| Phenotype Discovery |
|
|
| Scalability |
|
|
Autonomous Clinical Performance
In a multicentre evaluation of 1,124 cervical liquid-based cytology samples across four centres, the AI model achieved slide-level AUC values of 0.86-0.91 for LSIL+ and 0.89-0.97 for HSIL+. LSIL counts correlated strongly with human papillomavirus (HPV) positivity, and HSIL counts scaled with diagnostic severity. This demonstrates the system's clinical-grade autonomy for routine, scalable, and objective diagnostics.
Multicentre Validation: Real-World Diagnostic Reliability
Our platform underwent a rigorous multicentre evaluation across 1,124 cervical liquid-based cytology samples from four diverse centres. The AI model consistently demonstrated high slide-level diagnostic performance, achieving AUC values of 0.86-0.91 for LSIL+ and 0.89-0.97 for HSIL+. This robust validation across varying patient populations and preparation methods underscores the system's readiness for routine clinical application, providing objective, scalable, and consistent diagnostics to overcome human variability.
Calculate Your Potential ROI
Discover the transformative financial and operational benefits AI cytopathology can bring to your organization.
Estimated Annual Savings
$0
Hours Reclaimed Annually
0
Your AI Implementation Roadmap
Our structured approach ensures a seamless integration of autonomous cytopathology into your existing workflows, maximizing impact with minimal disruption.
Phase 1: Discovery & Assessment
Comprehensive evaluation of current diagnostic processes, data infrastructure, and specific clinical needs. We identify key integration points and tailor the solution to your environment.
Phase 2: Platform Deployment & Data Integration
On-site installation of whole-slide edge tomograph, secure network configuration, and integration with existing LIS/HIS. Initial data calibration and quality assurance are performed.
Phase 3: AI Model Customization & Validation
Fine-tuning of AI models to your specific sample types and diagnostic criteria. Rigorous validation against institutional benchmarks and expert cytologist review to ensure clinical-grade performance.
Phase 4: Workflow Integration & Training
Seamless integration of AI-driven analysis into your diagnostic workflow. Comprehensive training for your cytopathologists and technical staff on platform operation and CMD-based analysis.
Phase 5: Continuous Optimization & Support
Ongoing performance monitoring, regular software updates, and dedicated technical support. We ensure sustained high performance and adapt to evolving diagnostic needs.
Ready to Transform Your Diagnostics?
Connect with our AI specialists to explore how autonomous cytopathology can enhance accuracy, reduce turnaround times, and drive innovation in your practice.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat